Sirnaomics Ltd. (HKG:2257)
Hong Kong · Delayed Price · Currency is HKD 7.17
+0.27 (3.91%)
Feb 13, 2026, 4:08 PM HKT
Sirnaomics Market Cap
Sirnaomics has a market cap or net worth of 762.88 million as of February 13, 2026. Its market cap has increased by 150.38% in one year.
Market Cap
762.88M
Enterprise Value
655.79M
Revenue
7.45M
Ranking
n/a
PE Ratio
n/a
Stock Price
7.17
Market Cap Chart
Since December 30, 2021, Sirnaomics's market cap has decreased from 6.86B to 762.88M, a decrease of -88.88%. That is a compound annual growth rate of -41.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 13, 2026 | 762.88M | -6.52% |
| Dec 31, 2025 | 816.08M | 126.04% |
| Dec 31, 2024 | 361.03M | -88.38% |
| Dec 29, 2023 | 3.11B | -38.75% |
| Dec 30, 2022 | 5.07B | -36.82% |
| Dec 31, 2021 | 8.03B | 17.07% |
| Dec 30, 2021 | 6.86B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CANbridge Pharmaceuticals | 1.47B |
| Wuhan YZY Biopharma | 1.40B |
| Kintor Pharmaceutical | 1.38B |
| Beijing Biostar Pharmaceuticals | 1.35B |
| Shanghai Bio-heart Biological Technology | 1.31B |
| 3D Medicines | 1.13B |
| Brii Biosciences | 1.08B |
| Transcenta Holding | 1.06B |